Matilde Bocci

8PUBLICATIONS
29CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesPredictive and prognostic markersCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 16, 2026
A Small-Molecule Drug Conjugate Targeting FAP Exhibits Potent Activity in Dogs with Spontaneous Tumors.

|Feb 13, 2026
Combination with Immunocytokines Enhances the Anticancer Activity of Small Molecule Drug Conjugates and Radioligand Therapeutics Targeting Fibroblast Activation Protein.

Matilde Bocci, Laura Lucaroni, Domenico Ravazza

|Jun 30, 2025
Development of Multivalent FAP-Targeted Small Molecule-Drug Conjugates with Tailored MMAE Release Kinetics.

Matilde Bocci, Lucrezia Principi, Dario Neri

|Dec 24, 2024
Delivery of Monomethyl Auristatin F to the Tumor Microenvironment with Noninternalizing Fibroblast Activation Protein-Cleavable Small Molecule-Drug Conjugates Elicits Potent In Vivo Anticancer Activity.

Matilde Bocci, Lucrezia Principi, Ettore Gilardoni

|Jul 30, 2024
Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention.

Andrea Galbiati, Matilde Bocci, Silvia Gervasoni

|May 10, 2024
DNA-encoded chemical libraries enable the discovery of potent PSMA-ligands with substantially reduced affinity towards the GCPIII anti-target.

Laura Lucaroni, Sebastian Oehler, Tony Georgiev

Pageof 2

Frequent Collaborators

6 joint publications

Andrea Galbiati

6 joint publications

Ettore Gilardoni

6 joint publications

Samuele Cazzamalli

4 joint publications

Lucrezia Principi